| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.02B | -21.8% |
| Cost of Revenue | $8.40B | -22.2% |
| R&D Expense | $536.0M | -13.3% |
| SG&A Expense | $1.47B | -20.9% |
| Interest Expense | $492.0M | -6.3% |
| Pre-tax Income | $1.45B | -34.1% |
| Income Tax | $387.0M | -1.3% |
| Net Income | $5.87B | -9.3% |
| EPS (Basic) | $11.77 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.66B | +82.1% |
| Short-term Investments | $1.30B | — |
| Accounts Receivable | $1.57B | -24.0% |
| Inventory | $2.33B | -18.6% |
| Current Assets | $11.27B | +39.7% |
| Total Assets | $41.35B | -9.5% |
| Current Liabilities | $3.73B | -12.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $588.0M | -74.2% |
| Investing Cash Flow | $8.92B | +471.6% |
| Financing Cash Flow | -$7.67B | -17.8% |
| -1.3% |
| EPS (Diluted) | $11.75 | -1.2% |
| Long-term Debt |
| $8.14B |
| -23.4% |
| Total Liabilities | $14.34B | -23.1% |
| Stockholders' Equity | $26.57B | +0.5% |